The largest database of trusted experimental protocols

8 protocols using ym 58483

1

Isolation and Decidualization of Human Endometrial Stromal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human endometrial stromal cells (HESCs) were isolated from endometrial tissues as described previously [76 (link)]. Purified HESCs were expanded in maintenance medium of DMEM/F-12 (Invitrogen, Schwerte, Germany) containing 10% dextran-coated charcoal-treated fetal bovine serum (DCC-FBS; Invitrogen, UK) and 1% antibiotic-antimycotic solution (Invitrogen). Confluent monolayers were decidualized in DMEM/F-12 containing 2% DCC-FBS with 0.5 mM 8-bromo-cAMP (8-Br-cAMP; Sigma, Munich, Germany) with or without 10−6 M medroxyprogesterone acetate (MPA; Sigma) to induce a differentiated phenotype. Where indicated, the cells were treated with recombinant LEFTY2 (25 ng/ml; R&D Systems, Germany) as described previously [77 (link)]. Ionomycin was used at 1 μM (Sigma) and the Orai inhibitors: 2-APB, YM-58483, and MRS-1845(TOCRIS, Germany). Ishikawa cells, an endometrial epithelial-like cell line (ECACC 99040201) [28 (link), 29 (link)], were maintained in DMEM/F12 (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen), 2 mM L-glutamine, and 100 U/ml penicillin/streptomycin (Invitrogen). All cells were incubated at 37 °C in a humid atmosphere maintained at 5% (vol/vol) CO2, and routinely tested for mycoplasma infection.
+ Open protocol
+ Expand
2

Pharmacological Modulators of Ion Channels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thapsigargin, gadolinium chloride (GdCl3), 2-APB, capsaicin, menthol, and AITC were purchased from Sigma (St. Louis, MO, United States). Synta66 was purchased from Glixx Laboratories (Southborough, MA, United States). YM-58483 and ML-9 hydrochloride were purchased from Tocris (Minneapolis, MN, United States). TG, 2-APB, synta66, YM-58483, menthol, and AITC were dissolved in DMSO; capsaicin was dissolved in ethanol as stock solutions. All of them were further diluted in the bath solution as working solutions with a final 0.1% DMSO or ethanol.
+ Open protocol
+ Expand
3

Modulating Inflammatory Signaling in Ventricular Myocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isoproterenol (Sigma) and TNFα (R&D) were respectively used at 100 nM and 50 ng/mL, as previously reported26 (link). Neutralizing anti-TNFR1 or anti-TNFR2 antibodies (R&D) were preincubated 1 hour at 37 °C at a final concentration of 2.5 µg/mL. All pharmacological inhibitors were preincubated for 10 min. Orai pharmacological inhibitors YM58483 (Tocris) and Synta66 (Servier) were added at 1 µM. PLA2 activating peptide (R&D) and the cPLA2 inhibitor, methyl arachidonylfluorophosphonate (MAFP) (Sigma), were respectively used at 20 µg/mL and 4 µg/mL. Lipoxygenase and cycloxygenase inhibitors, nordihydroguaiaretic acid (NDGA) and indomethacin (Sigma), were used at 1 µM. Montelukast (Sigma) was used at 2 µM. To explore ventricular myocyte resistance to oxidative stress, we applied 100 µM of H2O2 (Sigma). Semapimod (MedKoo) was used in vitro on CD11b/c cells at 10 µM.
+ Open protocol
+ Expand
4

Murine Microglial Cell Lines and Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine BV2 microglial cell line was a generous gift from G. Hasko at the University of Medicine and Dentistry of New Jersey (Newark, NJ), and was generated by Blasi et al. [68 (link)]. RAW 264.7 macrophage cell line was purchased from ATCC (T1B-71). The N9 microglia cell line was a generous gift from N. Filipov at the University of Georgia [69 (link)]. CRISPR/Cas9 control and Crispr/Cas9 RGS10 knockout BV2 cell lines were established by our group, as previously described [4 (link)]. Wild type and RGS10 knockout breeder mice were gifted to us from J.K Lee at the University of Georgia, and have previously been used for neuroinflammation research[5 (link)-7 (link)]. The compounds used in this study are Lipopolysaccharide (Sigma-Aldrich: L2880), Thrombin (Sigma-Aldrich: T4648), Cyclosporin A (FagronLab: 803651), YM-58483 (Tocris Bioscience: 3939), and Thapsigargin (Abcam: ab120286).
+ Open protocol
+ Expand
5

Pharmacological Modulators of Neuronal Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs were used in the present study: the NK1R agonist GR73632 (Sakurada et al., 1999 (link)), PI3K-Akt pathway inhibitor LY294002 (Xiao et al., 2018 (link)), PKC inhibitors chelerythrine and GF109203X (Cho et al., 2001 (link)) (the latter more selectively targets PKCα/β (Asehnoune et al., 2005 (link))), and store-operated Ca2+ entry (SOCE) inhibitors YM-58483 and MRS-1845 were purchased from Tocris, Minneapolis, MN. CaMKII inhibitor KN93, ERK1/2 pathway inhibitor U0126 were obtained from Calbiochem, San Diego, CA. The L-type Ca2+ channel blocker nifedipine was from Sigma/RBI (St. Louis, MO). The ryanodine receptor antagonist dantrolene, the inositol-1, 4, 5-triphosphate receptor (IP3R) antagonist 2-APB were purchased from Santa Cruz (Dallas,Texas). The 5-HT3 receptor antagonist palonosetron and NK1 receptor antagonist netupitant were kindly provided by Helsinn Health Care (Lugano, Switzerland). GR73632 and palonosetron were dissolved in water. Nifedipine, dantrolene, 2-APB, YM-58483, MRS-1845, U0126, LY294002, chelerythrine and GF109203X were dissolved in 25% DMSO in water. Netupitant was dissolved in a 1:1:18 solution of emulphor™, ethanol and saline. All drugs were administered at a volume of 0.1 ml/10 g of body weight.
+ Open protocol
+ Expand
6

Ionomycin-Induced Calcium Signaling in Spinal Cord

Check if the same lab product or an alternative is used in the 5 most similar protocols
ionomycin calcium salt was purchased from Tocris Bioscience (Minneapolis, MN, USA) and used per the manufacturer’s recommendations. ionomycin was dissolved in DSMO first to make a 2 mM stock concentration. ionomycin was then dissolved in 2 mM Ca2+ aCSF at a final concentration of 1, 3, or 5 µM and perfused for 1 hour. Similarly, ionomycin was dissolved in zero Ca2+ aCSF for a final concentration of 3 µM and perfused for 1 hour. After 1 hour, the ionomycin buffer was washed out with either zero or normal 2 mM Ca2+ aCSF and images were collected every 15 minutes for an additional hour. To inhibit store-operated Ca2+ entry (SOCE), we pretreated spinal cords for 30 minutes with YM-58483 (an established blocker of SOCE; 500 nM; Tocris Bioscience) prior to ionomycin perfusion in aCSF. Thapsigargin, an irreversible Sarco-Endoplasmic Reticulum Ca2+ ATPase inhibitor, was purchased from AdipoGen Life Sciences (San Diego, CA, USA) and used per the manufacturer’s recommendations. Thapsigargin was dissolved in DMSO to make a 5 mM stock solution and further diluted in 2 mM Ca2+ aCSF to make a final concentration of 1 µM to pretreat the spinal cord for 60 minutes to empty calcium stores.
+ Open protocol
+ Expand
7

Quantifying Intracellular Calcium Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
YM-58483, KN-93, and PD98059 were purchased from Tocris (Minneapolis, MN). Cyclopiazonic acid (CPA), thapsigargin (TG), GdCl3, 2-aminoethyl diphenyl borate (2-APB), and LPS were purchased from Sigma (St. Louis, MO). They were dissolved in Milli-Q water or dimethyl sulfoxide (DMSO) as stock solutions and further diluted to final concentrations in 0.1 % DMSO.
+ Open protocol
+ Expand
8

Characterization of PAR2-mediated Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trypsin (from porcine pancreas; 2 µg/ml), elastase (from porcine pancreas; 3U/ml), aprotinin (20 µg/ml), amiloride (10 µM) and nifedipine (10 µM) were purchased from Sigma-Aldrich, Belgium. The selective PAR2 activator, 2-furoyl-LIGRLO-NH2 (5 µM), store operated calcium entry (SOCE) inhibitor YM58483 (1 µM) and Phospholipase C (PLC) inhibitor U73122 (5 µM) with its negative control U73343 (5 µM) were obtained from Tocris, Bioscience, UK. The specific PAR2 inhibitor I-191 (100 nM) was purchased at Axon Medchem, The Netherlands. Ionomycin (2 µM) was used as a positive control at the end of each experiment. All stock solutions were prepared in Milli Q water, DMSO or EtOH according to the manufacturers’ guidelines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!